Detalhe da pesquisa
1.
Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation.
Eur Heart J
; 44(3): 208-218, 2023 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36380569
2.
Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
Circulation
; 146(14): 1056-1066, 2022 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36065821
3.
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
Circulation
; 145(4): 242-255, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34985309
4.
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Lancet
; 399(10333): 1383-1390, 2022 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385695
5.
Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scores.
Am Heart J
; 261: 55-63, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990261
6.
Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction.
Am Heart J
; 266: 188-197, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648579
7.
Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation.
Europace
; 25(7)2023 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461214
8.
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference.
Europace
; 25(1): 6-27, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35894842
9.
Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation.
Circulation
; 143(19): 1863-1873, 2021 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33849281
10.
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model.
Am Heart J
; 251: 13-24, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35569564
11.
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society.
Europace
; 24(11): 1844-1871, 2022 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323922
12.
Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis.
J Thromb Thrombolysis
; 53(1): 74-82, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34338944
13.
Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) Investigators.
Am Heart J
; 233: 48-58, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33296688
14.
Risk markers of incident atrial fibrillation in patients with coronary heart disease.
Am Heart J
; 233: 92-101, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33400910
15.
Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study.
Diabetes Obes Metab
; 23(7): 1505-1517, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33625777
16.
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference.
Europace
; 23(3): 329-344, 2021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33555020
17.
Screening of biomarkers for prediction of multisite artery disease in patients with recent myocardial infarction.
Scand J Clin Lab Invest
; 81(5): 353-360, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34346268
18.
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
Eur Heart J
; 41(41): 4037-4046, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32984892
19.
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
N Engl J Med
; 377(16): 1513-1524, 2017 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28844193
20.
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis.
Europace
; 22(6): 870-877, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32215649